02749nam 22005295 450 991025386160332120200629194951.03-319-28570-X10.1007/978-3-319-28570-2(CKB)3710000000616294(EBL)4438949(SSID)ssj0001653947(PQKBManifestationID)16433166(PQKBTitleCode)TC0001653947(PQKBWorkID)14982866(PQKB)10911098(DE-He213)978-3-319-28570-2(MiAaPQ)EBC4438949(PPN)192774395(EXLCZ)99371000000061629420160304d2016 u| 0engur|n|---|||||txtccrUtility of Bromelain and N-Acetylcysteine in Treatment of Peritoneal Dissemination of Gastrointestinal Mucin-Producing Malignancies /by Afshin Amini, Samar Masoumi-Moghaddam, David L. Morris1st ed. 2016.Cham :Springer International Publishing :Imprint: Springer,2016.1 online resource (246 p.)Description based upon print version of record.3-319-28568-8 Includes bibliographical references and index.1 Peritoneal dissemination of gastrointestinal tumors -- 2 Mucins and tumor biology -- 3 Bromelain -- 4 N-acetylcysteine -- 5 A novel approach to peritoneal dissemination of mucin-expressing malignancies of gastrointestinal origin -- Summary and future potential directions.This volume will describe both growth-inhibitory and mucin-depleting effects of bromelain and N-acetylcysteine, on their own or in combination, in cancer. It will coherently review the pathophysiological aspects of the mucin glycoproteins in malignancies and provide an updated account of the status of bromelain and N-acetylcysteine in cancer therapy. The volume will develop the idea of using these two drugs as a combination formulation for mucin-depleting effects. .CancerResearchCancer Researchhttps://scigraph.springernature.com/ontologies/product-market-codes/B11001CancerResearch.Cancer Research.610Amini Afshinauthttp://id.loc.gov/vocabulary/relators/aut1063431Masoumi-Moghaddam Samarauthttp://id.loc.gov/vocabulary/relators/autMorris David Lauthttp://id.loc.gov/vocabulary/relators/autBOOK9910253861603321Utility of Bromelain and N-Acetylcysteine in Treatment of Peritoneal Dissemination of Gastrointestinal Mucin-Producing Malignancies2532366UNINA